Both in Pharmaceuticals
Actuate Therapeutics vs Lexaria Bioscience
Over the past year ACTU returned −94.8% and LEXX returned −74.2%; their daily moves had a correlation of 0.02.
ACTU −94.8% LEXX −74.2%Growth of $1, one year, split-adjusted
| Metric | ACTU | LEXX |
|---|---|---|
| Price | $0.3500 | $4.03 |
| Market cap | $8.4M | $8.5M |
| Today | +2.34% | +10.71% |
| 1 month | −60.0% | +45.5% |
| 6 months | −88.6% | −61.2% |
| Year to date | −94.3% | −56.5% |
| 1 year | −94.7% | −73.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 43.8× |
| Net cash | $4.4M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 161.0% | 195.6% |
| Short % of float | 19.2% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).